Proteinuria selectivity index predicts response to rituximab in adults with minimal change disease and focal segmental glomerulosclerosis-Reference-Cited by-同舟云学术

Proteinuria selectivity index predicts response to rituximab in adults with minimal change disease and focal segmental glomerulosclerosis

Published:2021-11-12 Issue: Volume: Page:
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Allinovi Marco¹^ORCID,Trivioli Giorgio¹²^ORCID,Lugli Gianmarco¹²^ORCID,Villanti Maurizio¹,Gianassi Iacopo¹,Antognoli Giulia¹,Romagnani Paola²,Vaglio Augusto²,Caroti Leonardo¹,Cirami Calogero Lino¹

Affiliation:

1. Nephrology, Dialysis and Transplant Unit, Careggi University Hospital, Florence, Italy

2. Nephrology Unit, Meyer Children's Hospital and Department of Biomedical Experimental and Clinical Sciences “Mario Serio”, University of Florence, Florence, Italy

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

https://academic.oup.com/ndt/advance-article-pdf/doi/10.1093/ndt/gfab323/42371568/gfab323.pdf

Reference14 articles.

1. Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - what is known and what is still unknown?;Gauckler;Autoimmun Rev,2020

2. Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach;De Vriese;J Am Soc Nephrol,2018

3. Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis;Hansrivijit;BMC Nephrol,2020

4. Persistent CD-19 depletion by rituximab is cost-effective in maintaining remission in calcineurin-inhibitor dependent podocytopathy;Ramachandran;Nephrology,2019

5. Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysis;Xue;Clin Kidney J,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group;Nephrology Dialysis Transplantation;2024-02-10

2. Proteinuria selectivity index in renal disease;Clinica Chimica Acta;2024-01

3. Efficacy of low-dose rituximab in minimal change disease and prevention of relapse;BMC Nephrology;2023-04-26

4. The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult;Kidney International Reports;2022-08

5. Rituximab Therapy for Adults with Nephrotic Syndromes: Standard Schedules or B Cell-Targeted Therapy?;Journal of Clinical Medicine;2021-12-13